SCHEMBL12840574

SCHEMBL12840574

CC(C)CC(=O)Nc1nc2c(nc1/C=C/c1ccccc1)-c1ccc(F)cc1CC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.41
IKBKB O14920 1/20 0.37
ADORA1 P30542 2/20 0.36
ADORA3 P0DMS8 2/20 0.36
ADORA2A P29274 1/20 0.36
MAPT P10636 1/20 0.36
SRD5A1 P18405 1/20 0.34
SRD5A2 P31213 1/20 0.34
POLB P06746 2/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
DHODH Q02127 2/20 0.34
TSHR P16473 1/20 0.34
GAA P10253 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
RAB9A P51151 1/20 0.33
CYP19A1 P11511 2/20 0.33
CYP11B1 P15538 2/20 0.33
CYP11B2 P19099 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12839610 0.90 ALOX5 (0.41) ALOX5IKBKBADORA1ADORA3ADORA2A
SCHEMBL12839715 0.89 ALOX5 (0.52) ALOX5IKBKBADORA1ADORA3ADORA2A
SCHEMBL12840656 0.88 SMN1; SMN2 (0.43) ALOX5IKBKBMAPTGAASMN1; SMN2
SCHEMBL12840573 0.87 ADORA3 (0.38) ADORA3SRD5A1SRD5A2POLBDHODH
SCHEMBL13067876 0.87 PAX3 (0.39) ADORA1ADORA3ADORA2AMAPTSRD5A1
SCHEMBL12840648 0.86 RAB9A (0.44) POLBTSHRSMN1; SMN2RAB9ALMNA
SCHEMBL12840242 0.85 ALOX5 (0.39) ALOX5IKBKBADORA1MAPTPOLB
SCHEMBL12839260 0.85 SNCA (0.45) ALOX5MAPTSRD5A1SRD5A2DHODH
SCHEMBL12840649 0.84 RAB9A (0.39) POLBGAASMN1; SMN2RAB9ALMNA
SCHEMBL13068066 0.84 AURKA (0.38) IKBKBSRD5A1SRD5A2DHODHRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed
EP-1666488-B1 FLUORESCENT PROTEIN CHISSO CORP (JP) 2010-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 ALOX5 3113/4885IKBKB 4405/4885ADORA1 3993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.